Emv Capital (EMVC) RNS Announcements

Add to Alert list
Date Time Source Announcement
04 Sep 2017 07:00 AM
RNS
ProAxsis is awarded a European CE Mark
24 Jul 2017 07:00 AM
RNS
ProAxsis awarded a Significant Innovate UK Grant
10 Jul 2017 12:00 PM
RNS
PDS Announces Clinical Collaboration with Merck
07 Jul 2017 07:00 AM
RNS
Glycotest Strengthens Intellectual Property Reach
26 Jun 2017 07:00 AM
RNS
Glycotest Update
21 Jun 2017 12:00 PM
RNS
Result of AGM
16 Jun 2017 10:05 AM
RNS
Holdings in Company
15 Jun 2017 02:52 PM
RNS
Holdings in Company
12 Jun 2017 12:02 PM
RNS
Results of General Meeting
12 Jun 2017 11:10 AM
RNS
Result of Placing
26 May 2017 03:52 PM
RNS
Notice of AGM and Annual Report & Accounts
26 May 2017 12:49 PM
RNS
Results of Placing and Subscription
25 May 2017 11:51 AM
RNS
Proposed Placing and Subscription
24 May 2017 07:00 AM
RNS
Vortex Initiates Clinical Research Studies
10 May 2017 07:00 AM
RNS
ProAxsis announces additional IP
05 May 2017 07:00 AM
RNS
ProAxsis Presents New Data at Major US Conference
24 Apr 2017 07:00 AM
RNS
BTG purchases Wanda's shares in Oncoverse
03 Apr 2017 07:00 AM
RNS
Full Year Results for the year ended 31 Dec 2016
31 Mar 2017 07:00 AM
RNS
Vortex Biosciences Announces Publications
27 Mar 2017 07:00 AM
RNS
Notice of Preliminary Results
22 Feb 2017 07:00 AM
RNS
Vortex Biosciences Launches VTX-1 Liquid Biopsy
15 Feb 2017 07:00 AM
RNS
Vortex Biosciences' CSO Wins SLAS Innovation Award
09 Feb 2017 07:00 AM
RNS
Vortex Biosciences' CSO Finalist for SLAS Award
30 Jan 2017 07:00 AM
RNS
Grant of Options to Directors
20 Dec 2016 07:00 AM
RNS
New CEO appointed to Wanda
16 Dec 2016 07:00 AM
RNS
Executed Warrants
18 Nov 2016 07:00 AM
RNS
Netscientific: Vortex Biosciences Analysis Data
03 Nov 2016 04:34 PM
RNS
Vortex Gains CE Mark and FDA Class 1 Registration
26 Oct 2016 12:30 PM
RNS
Vortex Biosciences Appoints Non-Executive Director
30 Sep 2016 07:00 AM
RNS
ProAxsis Gains CE Mark for its Respiratory Test
27 Sep 2016 07:00 AM
RNS
NetScientific Interim Results
23 Sep 2016 07:00 AM
RNS
Wanda Technology Selected by 24Hr HomeCare
12 Sep 2016 07:00 AM
RNS
Glycotest strengthens IP portfolio
08 Sep 2016 07:00 AM
RNS
Wanda Appoints Digital Health Non-Exec Director
06 Sep 2016 07:00 AM
RNS
Notice of Interim Results
19 Aug 2016 07:00 AM
RNS
Wanda Launches First Consumer App
18 Aug 2016 07:06 AM
RNS
Vortex Biosciences Appoints Experts to New SAB
03 Aug 2016 07:00 AM
RNS
Vortex Licenses Patents From Harvard University
28 Jul 2016 07:00 AM
RNS
Change of Adviser
27 Jul 2016 07:00 AM
RNS
Wanda Appoints Medical Director
22 Jul 2016 07:00 AM
RNS
A to Z Home Health Care selects Wanda technologies
27 Jun 2016 07:00 AM
RNS
Grant of Options to Director
15 Jun 2016 02:13 PM
RNS
Result of AGM
14 Jun 2016 07:00 AM
RNS
Vortex Biosciences appoints Chairman of SAB
14 Jun 2016 07:00 AM
RNS
NetScientific hosts Capital Markets Day
10 Jun 2016 07:30 AM
RNS
Confirmed Start Date for Ian Postlethwaite as CFO
07 Jun 2016 07:00 AM
RNS
Portfolio PDS Biotechnology presents at BIO 2016
23 May 2016 09:00 AM
RNS
Notice of AGM
18 Apr 2016 07:00 AM
RNS
NetScientific's Vortex presents data at AACR
13 Apr 2016 07:00 AM
RNS
PDS Biotechnology Reports Positive Phase 1 Results

EMV Capital is a London venture capital company that invests in early-stage, IP-rich, technology and life sciences companies in the UK and internationally.

It is listed on AIM under the ticker EMVC.

EMVC share price launched at 1,620p in 2013.

UK 100

Latest directors dealings